Rhaeos, Inc. Receives $1.5 Million Blueprint MedTech Grant from the NIH to Transform Hydrocephalus Management
EVANSTON, Ill., Oct. 9, 2023 /PRNewswire/ — Rhaeos, Inc, a clinical stage medical device technology company, is pleased to announce that it has been awarded a $1.5 million grant (Federal Award # 1UG3NS130338) from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) through its Blueprint MedTech program. This grant will further the development of its FDA breakthrough designated medical technology designed to transform the management of hydrocephalus, a neurological condition affecting over one million Americans.
